{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T14:39:28Z","timestamp":1789655968678,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jvir.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Vascular and Interventional Radiology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/j.jvir.2023.12.009","type":"journal-article","created":{"date-parts":[[2023,12,18]],"date-time":"2023-12-18T19:05:20Z","timestamp":1702926320000},"page":"506-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Locoregional Therapies for Hepatocellular Carcinoma prior to Liver Transplant: Comparative Pathologic Necrosis, Radiologic Response, and Recurrence"],"prefix":"10.1016","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-8307-1441","authenticated-orcid":false,"given":"McKenzie","family":"Mosenthal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5608-3808","authenticated-orcid":false,"given":"William","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Cotler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianzhong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Borge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0217-5821","authenticated-orcid":false,"given":"Angelo","family":"Malamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2086-0150","authenticated-orcid":false,"given":"David","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tarita","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1541-7568","authenticated-orcid":false,"given":"Anugayathri","family":"Jawahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6034-1355","authenticated-orcid":false,"given":"Parag","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1201-4026","authenticated-orcid":false,"given":"Christopher","family":"Molvar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jvir.2023.12.009_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL Clinical Practice Guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2023.12.009_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2023.12.009_bib3","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1007\/s00270-020-02712-1","article-title":"Evaluation of medium-term efficacy of Y90 radiation segmentectomy vs percutaneous microwave ablation in patients with solitary surgically unresectable < 4 cm hepatocellular carcinoma: a propensity score matched study","volume":"44","author":"Arndt","year":"2021","journal-title":"Cardiovasc Intervent Radiol"},{"key":"10.1016\/j.jvir.2023.12.009_bib4","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jvir.2017.02.018","article-title":"Segmental yttrium-90 radioembolization versus segmental chemoembolization for localized hepatocellular carcinoma: results of a single-center, retrospective, propensity score-matched study","volume":"28","author":"Padia","year":"2017","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2023.12.009_bib5","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.ijrobp.2009.10.062","article-title":"Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization","volume":"79","author":"Riaz","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jvir.2023.12.009_bib6","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jvir.2014.03.030","article-title":"Superselective yttrium-90 radioembolization for hepatocellular carcinoma yields high response rates with minimal toxicity","volume":"25","author":"Padia","year":"2014","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2023.12.009_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.12659\/AOT.902595","article-title":"Long-term outcome after liver transplantation for hepatocellular carcinoma following yttrium-90 radioembolization bridging treatment","volume":"22","author":"Radunz","year":"2017","journal-title":"Ann Transplant"},{"key":"10.1016\/j.jvir.2023.12.009_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.adro.2015.12.003","article-title":"Comparison of outcomes between SBRT, yttrium-90 radioembolization, transarterial chemoembolization, and radiofrequency ablation as bridge to transplant for hepatocellular carcinoma","volume":"1","author":"Mohamed","year":"2016","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.jvir.2023.12.009_bib9","unstructured":"American College of Radiology. Liver Reporting & Data System Lexicon. Available at: https:\/\/www.acr.org\/-\/media\/ACR\/Files\/RADS\/LI-RADS\/LI-RADS-2018-Core.pdf. Accessed January 9, 2024."},{"key":"10.1016\/j.jvir.2023.12.009_bib10","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1148\/radiol.212340","article-title":"Impact of reference standard on CT, MRI, and contrast-enhanced US LI-RADS diagnosis of hepatocellular carcinoma: a meta-analysis","volume":"303","author":"van der Pol","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2023.12.009_bib11","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/hep.31318","article-title":"Liver transplantation following yttrium-90 radioembolization: 15-year experience in 207-patient cohort","volume":"73","author":"Gabr","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2023.12.009_bib12","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1148\/radiol.12121698","article-title":"New OPTN\/UNOS policy for liver transplant allocation: standardization of liver imaging, diagnosis, classification, and reporting of hepatocellular carcinoma","volume":"266","author":"Wald","year":"2013","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2023.12.009_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/SLA.0000000000002381","article-title":"Impact of pretransplant bridging locoregional therapy for patients with hepatocellular carcinoma within Milan criteria undergoing liver transplantation: analysis of 3601 patients from the US multicenter HCC transplant consortium","volume":"266","author":"Agopian","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2023.12.009_bib14","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A\u00a0comparative analysis of transarterial downstaging for hepatocellular carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jvir.2023.12.009_bib16","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1093\/biomet\/38.1-2.141","article-title":"Note on an exact treatment of contingency, goodness of fit and other problems of significance","volume":"38","author":"Freeman","year":"1951","journal-title":"Biometrika"},{"key":"10.1016\/j.jvir.2023.12.009_bib17","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1097\/SLA.0000000000001384","article-title":"Complete pathologic response to pretransplant locoregional therapy for hepatocellular carcinoma defines cancer cure after liver transplantation: analysis of 501 consecutively treated patients","volume":"262","author":"Agopian","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2023.12.009_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jvir.2018.11.037","article-title":"Association of complete radiologic and pathologic response following locoregional therapy before liver transplantation with long-term outcomes of hepatocellular carcinoma: a retrospective study","volume":"30","author":"Habibollahi","year":"2019","journal-title":"J\u00a0Vasc Interv Radiol"},{"key":"10.1016\/j.jvir.2023.12.009_bib19","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/lt.20472","article-title":"Tumor size predicts vascular invasion and histologic grade: implications for selection of surgical treatment for hepatocellular carcinoma","volume":"11","author":"Pawlik","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jvir.2023.12.009_bib20","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/ajt.12684","article-title":"Recurrence of hepatocellular carcinoma: importance of mRECIST response to chemoembolization and tumor size","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.jvir.2023.12.009_bib21","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/hep.30406","article-title":"Stereotactic radiofrequency ablation of hepatocellular carcinoma: a histopathological study in explanted livers","volume":"70","author":"Bale","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2023.12.009_bib22","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1148\/radiol.2343040153","article-title":"Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver","volume":"234","author":"Lu","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/j.jvir.2023.12.009_bib23","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1002\/lt.20469","article-title":"Percutaneous ablation procedures in cirrhotic patients with hepatocellular carcinoma submitted to liver transplantation: assessment of efficacy at explant analysis and of safety for tumor recurrence","volume":"11","author":"Pompili","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jvir.2023.12.009_bib24","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/01.sla.0000143301.56154.95","article-title":"Radiofrequency ablation of small hepatocellular carcinoma in cirrhotic patients awaiting liver transplantation: a prospective study","volume":"240","author":"Mazzaferro","year":"2004","journal-title":"Ann Surg"},{"key":"10.1016\/j.jvir.2023.12.009_bib25","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.1002\/cncr.25314","article-title":"Midterm outcomes in patients with intermediate-sized hepatocellular carcinoma: a randomized controlled trial for determining the efficacy of radiofrequency ablation combined with transcatheter arterial chemoembolization","volume":"116","author":"Morimoto","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.jvir.2023.12.009_bib26","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1200\/JCO.2012.42.9936","article-title":"Radiofrequency ablation with or without transcatheter arterial chemoembolization in the treatment of hepatocellular carcinoma: a prospective randomized trial","volume":"31","author":"Peng","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jvir.2023.12.009_bib27","doi-asserted-by":"crossref","first-page":"225","DOI":"10.21037\/hbsn.2016.01.05","article-title":"Radiofrequency and microwave ablation in combination with transarterial chemoembolization induce equivalent histopathologic coagulation necrosis in hepatocellular carcinoma patients bridged to liver transplantation","volume":"5","author":"Vasnani","year":"2016","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jvir.2023.12.009_bib28","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/hep.27057","article-title":"Unresectable solitary hepatocellular carcinoma not amenable to radiofrequency ablation: multicenter radiology-pathology correlation and survival of radiation segmentectomy","volume":"60","author":"Vouche","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jvir.2023.12.009_bib29","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1007\/s00259-020-04976-8","article-title":"Correlation of Y90-absorbed radiation dose to pathological necrosis in hepatocellular carcinoma: confirmatory multicenter analysis in 45 explants","volume":"48","author":"Gabr","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.jvir.2023.12.009_bib30","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2468-1253(22)00091-7","article-title":"Radiation segmentectomy for curative intent of unresectable very early to early stage hepatocellular carcinoma (RASER): a single-centre, single-arm study","volume":"7","author":"Kim","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jvir.2023.12.009_bib31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.21037\/jgo.2018.05.01","article-title":"Stereotactic body radiation therapy following transarterial chemoembolization for unresectable hepatocellular carcinoma","volume":"9","author":"Buckstein","year":"2018","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.jvir.2023.12.009_bib32","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jhep.2017.02.022","article-title":"Stereotactic body radiotherapy vs. TACE or RFA as a bridge to transplant in patients with hepatocellular carcinoma. An intention-to-treat analysis","volume":"67","author":"Sapisochin","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jvir.2023.12.009_bib33","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s00330-019-06376-5","article-title":"Evaluation of treatment response in hepatocellular carcinoma in the explanted liver with Liver Imaging Reporting and Data System version 2017","volume":"30","author":"Seo","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jvir.2023.12.009_bib34","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1053\/j.sult.2021.03.002","article-title":"Imaging after locoregional therapy for hepatocellular carcinoma with emphasis on LIRADS treatment response assessment criteria","volume":"42","author":"Bajaj","year":"2021","journal-title":"Semin Ultrasound CT MR"},{"key":"10.1016\/j.jvir.2023.12.009_bib35","doi-asserted-by":"crossref","first-page":"6493","DOI":"10.1007\/s00330-022-08732-4","article-title":"Assessment of HCC response to yttrium-90 radioembolization with gadoxetate disodium MRI: correlation with histopathology","volume":"32","author":"Vietti Violi","year":"2022","journal-title":"Eur Radiol"}],"container-title":["Journal of Vascular and Interventional Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104432300903X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S105104432300903X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T06:12:31Z","timestamp":1760940751000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S105104432300903X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S105104432300903X"],"URL":"https:\/\/doi.org\/10.1016\/j.jvir.2023.12.009","relation":{},"ISSN":["1051-0443"],"issn-type":[{"value":"1051-0443","type":"print"}],"subject":[],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Locoregional Therapies for Hepatocellular Carcinoma prior to Liver Transplant: Comparative Pathologic Necrosis, Radiologic Response, and Recurrence","name":"articletitle","label":"Article Title"},{"value":"Journal of Vascular and Interventional Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jvir.2023.12.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 SIR, 2023","name":"copyright","label":"Copyright"}]}}